Antimicrobial peptides with stability toward tryptic degradation

Biochemistry

Volumn 47, Issue 12, 2008, Pages 3777-3788

  Svenson, Johan ^a   Stensen, Wenche ^a,b   Brandsdal, Bjørn Olav ^a   Haug, Bengt Erik ^a,c   Monrad, Johnny ^a   Svendsen, John S ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b LYTIX BIOPHARMA AS   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIODEGRADATION; DISSOCIATION; METABOLISM; PROTEOLYSIS;

ANTIMICROBIAL PEPTIDES; GASTROINTESTINAL TRACTS; TRYPTIC DEGRADATION;

PEPTIDES;

POLYPEPTIDE ANTIBIOTIC AGENT; TRYPSIN;

ADDITION REACTION; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DISSOCIATION CONSTANT; HALF LIFE TIME; ISOTHERMAL TITRATION CALORIMETRY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN STABILITY;

ANTIMICROBIAL CATIONIC PEPTIDES; CALORIMETRY; COMPUTER SIMULATION; DRUG STABILITY; MODELS, MOLECULAR; OLIGOPEPTIDES; PEPTIDE LIBRARY; TRYPSIN;

EID: 41149108031     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi7019904     Document Type: Article

References (45)

1. Werle, M., and Bernkop-Schnurch, A. (2006) Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids 30, 351-367.
2. Bergmann, M., and Ross, W. F. (1936) On proteolytic enzymes. X. The enzymes of papain and their activation. J. Biol. Chem. 114, 717-726.
3. Leung, D., Abbenante, G., and Fairlie, D. P. (2000) Protease inhibitors: Current status and future prospects. J. Med. Chem. 43, 305-341.
4. Powers, J. C., and Harper, J. W. (1986) Inhibitors of serine proteinases, in Proteinase Inhibitors (Barrett, A. J., and Salvesen, G., Eds.) pp 56-152, Elsevier, Amsterdam.
5. Brinckerhoff, L. H., Kalashnikov, V. V., Thompson, L. W., Yamshchikov, G. V., Pierce, R. A., Galavotti, H. S., Engelhard, V. H., and Slingluff, C. L. (1999) Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: Implications for peptide vaccines. Int. J. Cancer 83, 326-334.
6. Fairlie, D. P., Abbenante, G., and March, D. R. (1995) Macrocyclic Peptidomimetics - Forcing Peptides into Bioactive Conformations. Curr. Med. Chem. 2, 654-686.
7. Aurelio, L., Brownlee, R. T. C., and Hughes, A. B. (2004) Synthetic preparation of N-methyl-alpha-amino acids. Chem. Rev. 104, 5823-5846.
8. Harris, A. G. (1994) Somatostatin and Somatostatin Analogs - Pharmacokinetics and Pharmacodynamic Effects. Gut 35, 1-4.
9. Braun, K., Kuhl, P., Bernd, M., and Kutscher, B. (2001) Stability of several LHRH antagonists against proteolytic enzymes and identification of degradation products by mass spectrometry. Pharmazie 56, 45-49.
10. Darlak, K., Benovitz, D. E., Spatola, A. F., and Grzonka, Z. (1988) Dermorphin Analogs - Resistance to In vitro Enzymatic Degradation Is Not Always Increased by Additional D-Amino-Acid Substitutions. Biochem. Biophys. Res. Commun. 156, 125-130.
11. Osapay, G., Prokai, L., Kim, H. S., Medzihradszky, K. F., Coy, D. H., Liapakis, G., Reisine, T., Melacini, G., Zhu, Q., Wang, S. H. H., Mattern, R. H., and Goodman, M. (1997) Lanthionine-somatostatin analogs: Synthesis, characterization, biological activity, and enzymatic stability studies. J. Med. Chem. 40, 2241-2251.
12. Rozek, A., Powers, J. P. S., Friedrich, C. L., and Hancock, R. E. W. (2003) Structure-based design of an indolicidin peptide analogue with increased protease stability. Biochemistry 42, 14130-14138.
13. Reissmann, S., and Imhof, D. (2004) Development of conformationally restricted analogues of bradykinin and somatostatin using constrained amino acids and different types of cyclization. Curr. Med. Chem. 11, 2823-2844.
14. Johnson, S. L., and Pellecchia, M. (2006) Structure- and fragment-based approaches to protease inhibition. Curr. Top. Med. Chem. 6, 317-329.
15. Xue, F. T., and Seto, C. T. (2005) Selective inhibitors of the serine protease plasmin: Probing the S3 and S3′ subsites using a combinatorial library. J. Med. Chem. 48, 6908-6917.
16. Vajda, T., and Szabo, T. (1976) Specificity of Trypsin and Alpha-Chymotrypsin Towards Neutral Substrates. Acta Biochim. Biophys. Hung. 11, 287-294.
17. Hancock, R. E. W., and Sahl, H. G. (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24, 1551-1557.
18. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.
19. Marr, A. K., Gooderham, W. J., and Hancock, R. E. W. (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6, 468-472.
20. Eliassen, L. T., Berge, G., Sveinbjornsson, B., Svendsen, J. S., Vorland, L. H., and Rekdal, O. (2002) Evidence for a direct antitumor mechanism of action of bovine lactoferricin. Anticancer Res. 22, 2703-2710.
21. Strom, M. B., Haug, B. E., Skar, M. L., Stensen, W., Stiberg, T., and Svendsen, J. S. (2003) The pharmacophore of short cationic antibacterial peptides. J. Med. Chem. 46, 1567-1570.
22. Haug, B. E., Stensen, W., Stiberg, T., and Svendsen, J. S. (2004) Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides. J. Med. Chem. 47, 4159-4162.
23. Haug, B. E., Strom, M. B., and Svendsen, J. S. (2007) The medicinal chemistry of short lactoferricin-based antibacterial peptides. Curr. Med. Chem. 14, 1-18.
24. Hedstrom, L., Perona, J. J., and Rutter, W. J. (1994) Converting Trypsin to Chymotrypsin - Residue-172 Is a Substrate-Specificity Determinant. Biochemistry 33, 8757-8763.
25. Hedstrom, L. (2002) Serine protease mechanism and specificity. Chem. Rev. 102, 4501-4523.
26. Coste, J., Frerot, E., and Jouin, P. (1994) Coupling N-Methylated Amino-Acids Using Pybrop and Pyclop Halogenophosphonium Salts - Mechanism and Fields of Application. J. Org. Chem. 59, 2437-2446.
27. Sjago, M., and Löw, M. (1979) Untersuchungen über den enzymatischen abbau von tert-butyltryptophan-haltigen peptides. Hoppe-Seyler's Z. Phys. Chem. 360, 9-12.
28. http://www-users.med.cornell.edu/~spon/picu/calc/halfcalc.htm.
29. Amsterdam, D. (1996) Susceptibility testing of antimicrobials in liquid media, in Antibiotics in Laboratory Medicine (Lorian, V., Ed.) 4th ed., pp 75-78, Williams and Wilkins, Baltimore, MD.
30. Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., and Olson, A. J. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19, 1639-1662.
31. Marquart, M., Walter, J., Deisenhofer, J., Bode, W., and Huber, R. (1983) The Geometry of the Reactive Site and of the Peptide Groups in Trypsin, Trypsinogen and Its Complexes with Inhibitors. Acta Crystallogr. B 39, 480-490.
32. Brandsdal, B. O., Smalas, A. O., and Aqvist, J. (2001) Electrostatic effects play a central role in cold adaptation of trypsin. FEBS Lett. 499, 171-175.
33. Thompson, M. A. Planaria Software LLC, Seattle, WA (http://www.arguslab. com).
34. Haug, B. E., Stensen, W., and Svendsen, J. S. (2007) Application of the Suzuki-Miyaura cross-coupling to increase antimicrobial potency generates promising novel antibacterials. Bioorg. Med. Chem. Lett. 17, 2361-2364.
35. Leavitt, S., and Freire, E. (2001) Direct measurement of protein binding energetics by isothermal titration calorimetry. Curr. Opin. Struct. Biol. 11, 560-566.
36. Perozzo, R., Folkers, G., and Scapozza, L. (2004) Thermodynamics of protein-ligand interactions: History, presence, and future aspects. J. Recept. Signal Transduction 24, 1-52.
37. Shannon, J. (2001) Using proteinases for Edman sequence analysis and peptide mapping, in Proteolytic enzymes (Beynon, R., and Bond, J. S., Eds.) pp 187-210, Oxford, New York.
38. Perona, J. J., and Craik, C. S. (1997) Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold. J. Biol. Chem. 272, 29987-29990.
39. Schechter, I., and Berger, A. (1967) On Size of Active Site in Proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
40. Hedstrom, L., Szilagyi, L., and Rutter, W. J. (1992) Converting Trypsin to Chymotrypsin - the Role of Surface Loops. Science 255, 1249-1253.
41. Tyndall, J. D. A., Nall, T., and Fairlie, D. P. (2005) Proteases universally recognize beta strands in their active sites. Chem. Rev. 105, 973-999.
42. Perona, J. J., and Craik, C. S. (1995) Structural Basis of Substrate-Specificity in the Serine Proteases. Protein Sci. 4, 337-360.
43. Brady, K., and Abeles, R. H. (1990) Inhibition of Chymotrypsin by Peptidyl Trifluoromethyl Ketones - Determinants of Slow-Binding Kinetics. Biochemistry 29, 7608-7617.
44. Grzesiak, A., Helland, R., Smalas, A. O., Krowarsch, D., Dadlez, M., and Otlewski, J. (2000) Substitutions at the P-1′ position in BPTI strongly affect the association energy with serine proteinases. J. Mol. Biol. 301, 205-217.
45. Reid, R. C., Pattenden, L. K., Tyndall, J. D. A., Martin, J. L., Walsh, T., and Fairlie, D. P. (2004) Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries. J. Med. Chem. 47, 1641-1651.